VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
about
Epidemics to eradication: the modern history of poliomyelitisAnalysis of codon usage and nucleotide composition bias in poliovirusesA vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuationVirus attenuation by genome-scale changes in codon pair biasEstablishment of a poliovirus oral infection system in human poliovirus receptor-expressing transgenic mice that are deficient in alpha/beta interferon receptorRewiring the severe acute respiratory syndrome coronavirus (SARS-CoV) transcription circuit: engineering a recombination-resistant genomeEvidence for emergence of diverse polioviruses from C-cluster coxsackie A viruses and implications for global poliovirus eradicationThe role of research in viral disease eradication and elimination programs: lessons for malaria eradicationWidespread recombination, reassortment, and transmission of unbalanced compound viral genotypes in natural arenavirus infectionsDoes mutational robustness inhibit extinction by lethal mutagenesis in viral populations?Antiviral activity of 3(2H)- and 6-chloro-3(2H)-isoflavenes against highly diverged, neurovirulent vaccine-derived, type2 poliovirus sewage isolatesAn interaction between glutathione and the capsid is required for the morphogenesis of C-cluster enterovirusesEthics, economics, and the use of primaquine to reduce falciparum malaria transmission in asymptomatic populationsHigh Incidence of Mammalian Orthoreovirus Identified by Environmental Surveillance in TaiwanThe test-tube synthesis of a chemical called poliovirus. The simple synthesis of a virus has far-reaching societal implicationsKinetics of poliovirus shedding following oral vaccination as measured by quantitative reverse transcription-PCR versus culture.A large vaccine-derived poliovirus outbreak on Madura Island--Indonesia, 2005.Recombination between poliovirus and coxsackie A viruses of species C: a model of viral genetic plasticity and emergence.Population Immunity against Serotype-2 Poliomyelitis Leading up to the Global Withdrawal of the Oral Poliovirus Vaccine: Spatio-temporal Modelling of Surveillance Data.Neurovirulent vaccine-derived polioviruses in sewage from highly immune populations.Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar.Impact of exogenous sequences on the characteristics of an epidemic type 2 recombinant vaccine-derived poliovirus.Estimating the extent of vaccine-derived poliovirus infection.Recombination between polioviruses and co-circulating Coxsackie A viruses: role in the emergence of pathogenic vaccine-derived polioviruses.Antiviral Activity of Pocapavir in a Randomized, Blinded, Placebo-Controlled Human Oral Poliovirus Vaccine Challenge Model.OPV strains circulation in HIV infected infants after National Immunisation Days in Bangui, Central African Republic.Global polio perspective.Public health workers and vaccination coverage in Eastern China: a health economic analysisNatural type 3/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region.The frequency and biodiversity of poliovirus and non-polio enterovirus strains isolated from healthy children living in a limited area in Romania.Inducing dose sparing with inactivated polio virus formulated in adjuvant CAF01.Emergence and re-emergence of viral diseases of the central nervous system.Detection of Emerging Vaccine-Related Polioviruses by Deep Sequencing.Maintenance and Intensification of Bivalent Oral Poliovirus Vaccine Use Prior to its Coordinated Global Cessation.Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus.Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China.Mutations in the highly conserved SLQYLA motif of Vif in a simian-human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome.Genetic relationship between cocirculating Human enteroviruses species C.Towards a human oral vaccine for anthrax: the utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategyEmergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China.
P2860
Q21245132-FB90F3B8-A346-4E8A-A28A-AFAC9DB37D5FQ24612009-4E161B59-FD65-4AA6-ADF4-A0F3F4E1832FQ24631128-813ACBFA-8FE9-4E10-B223-AE08A1772B97Q24644457-E155D52F-BDCE-4A62-9514-F86F15F6175FQ24676247-9F8117C2-0F5B-4388-AA38-9B8F04B3EF70Q24682935-60B5B4E2-54E4-4D39-940B-1AC1B1CE86B0Q24683132-E505D97B-796A-4575-8AE5-D14067023FD2Q26700366-69D0C9DB-8D1C-4579-BD85-546C267AF5FAQ27319869-0152E493-86A0-45ED-B21F-6014D130C6EAQ28474346-DCD9ACEE-FD6E-4A6B-A562-C64B7F7C3072Q28478276-FF1D1140-4F35-48B5-B6B4-5C174C2C42ECQ28537710-8603403D-70ED-4B60-A02D-2D184A7D35E5Q28542069-E68A5F5A-8A3F-4DD2-BC47-BC125E5EA2D0Q28607587-B0FFE42A-3181-4B50-B82F-D9552CBE2CC7Q28768487-43A254D8-0A7D-4ECE-9EF9-0E485C7A93AAQ30301366-9B22EEF4-D1F3-4901-B93E-860AB3207EC1Q30840117-7CCE46F9-986B-49E2-87E1-75722A5DA895Q31034162-8E3FB8AB-E42A-4D6D-B9B6-D5E437417263Q31134681-B11C52C6-EC21-401D-AF0F-470F9BCA473DQ33267329-F1D16FF9-AF28-4EE6-B591-47B0034545BAQ33310740-97492E31-845B-4577-90E9-754E14264585Q33346729-48CB30F9-E4A2-422C-94DB-4012571B8AA1Q33380220-ED6D3DF5-A9CC-4002-A1E1-3CC47C7C25ABQ33438422-8F720E7C-C13B-42B3-B0F9-A30CD51EFA1FQ33568783-2E11037F-4186-429E-B346-ED2031B8C2C5Q33581150-9985FC79-B332-4F93-8545-05E2DB087EFFQ33672632-8260F64B-BDE5-4EA0-B7A2-0206D82BF1DBQ33742385-98089F4A-D71A-4AC5-A804-22761500DE33Q33784842-02FE4734-93A5-413C-9719-5A8F775E5784Q33790017-528C8469-08F0-4449-A612-4E8B6BFCDB1BQ33793770-AF09284C-E1FF-4543-9724-70E236D0B484Q33812013-F1024932-F9C0-4BA5-BF0E-A113EF55E0F3Q33832828-7FE49C96-7981-416C-8C29-DD1FB1AEEA3EQ33873406-52CA8CB6-BC51-4B4B-9A0A-AABF6EFE27D4Q33877518-DBE6C3F4-EB9C-4BBE-88D8-FC9292271269Q33899399-AB7F72B6-CFA2-41A4-951B-7768BF6A4741Q33925040-7733E7BE-C2BA-4BDC-9BCB-C7861C50942CQ34024060-A085D5D0-DE1B-45D4-9CE6-8F256E9079D0Q34025527-D93EFFBB-7B35-4242-A42E-EFAA202333F9Q34120449-CB43FD7B-56C7-452C-B2F3-4F54F5481C4F
P2860
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
description
2005 nî lūn-bûn
@nan
2005 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@ast
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@en
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@en-gb
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@nl
type
label
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@ast
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@en
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@en-gb
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@nl
altLabel
Vaccine-derived polioviruses and the endgame strategy for global polio eradication
@en
prefLabel
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@ast
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@en
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@en-gb
VACCINE-DERIVED POLIOVIRUSES AND THE ENDGAME STRATEGY FOR GLOBAL POLIO ERADICATION *
@nl
P2093
P3181
P1476
Vaccine-derived polioviruses and the endgame strategy for global polio eradication
@en
P2093
Esther M. de Gourville
Olen M. Kew
Roland W. Sutter
Walter R. Dowdle
P304
P3181
P356
10.1146/ANNUREV.MICRO.58.030603.123625
P407
P577
2005-10-01T00:00:00Z